News & Events

Biotech Boom Fuels Parenteral Market

SYM BLOG

Colin MacKay, CEO of Symbiosis Pharmaceutical Services assesses the trends driving parenteral manufacturing in this guest blog as featured on Contract Pharma.

“There are a number of factors that are influencing the growing demand for aseptically-processed parenteral products. The continued growth of the biotech sector and increased funding available are major drivers, while mergers and acquisitions within the contract manufacturing organization (CMO) space are changing the landscape and service options available for drug developers.

The article explores the trends that are fueling the demand for parenteral manufacturing, the changing structure of the CMO industry and the impact on biotech and small pharma companies needing to outsource their clinical manufacturing requirements.”

Read the full article here via Contract Pharma.

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.